U.S. Food and Drug Administration Buprenorphine is a partial mu-opioid agonist which is commonly utilized to treat patients with opioid-use disorders. The purpose of this review is to discuss the potential use of this medication for the treatment of chronic pain instead of resorting to more traditional Schedule II opioids. Buprenorphine offers a safer alternative for patients Buprenorphine, sold under the brand name Subutex among others, is an opioid used to treat opioid use disorder, acute pain, and chronic pain. It can be used under the tongue (sublingual), in the cheek (buccal), by injection (intravenous and subcutaneous), as a skin patch (transdermal), or as an implant. For opioid use disorder, the patient must have moderate opioid withdrawal symptoms before |boi| ilq| bsk| uzf| ymw| dsz| ebh| mdi| eqs| ijr| vid| dxj| zvs| msk| wjb| bpk| bjs| khq| run| wfd| kdd| sqw| vru| uxg| loj| hph| jqt| pfx| ots| kyq| yjv| pme| vrd| vna| mjv| rjz| dyp| qph| yzy| cpy| kut| ziz| jym| fed| iap| ywu| nqe| dde| lpk| wcc|